Stoxx Europe 50
4.440,12
PKT
+1,78
PKT
+0,04
%
Werbung
Analysen zu Stoxx Europe 50-Werten
Datum | Rating | Analyst | |
---|---|---|---|
13.02.25 | Unilever Overweight | JP Morgan Chase & Co. | |
13.02.25 | Münchener Rückversicherungs-Gesellschaft Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
13.02.25 | AXA Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
13.02.25 | Allianz Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
13.02.25 | Siemens Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
13.02.25 | Unilever Outperform | Bernstein Research | |
13.02.25 | ING Group Verkaufen | DZ BANK | |
13.02.25 | Siemens Outperform | Bernstein Research | |
13.02.25 | UniCredit Hold | Deutsche Bank AG | |
13.02.25 | Nestlé Market-Perform | Bernstein Research | |
13.02.25 | BAT Neutral | Goldman Sachs Group Inc. | |
13.02.25 | BASF Buy | Goldman Sachs Group Inc. | |
13.02.25 | Siemens Buy | Goldman Sachs Group Inc. | |
13.02.25 | Nestlé Buy | Goldman Sachs Group Inc. | |
13.02.25 | Unilever Neutral | Goldman Sachs Group Inc. | |
13.02.25 | Nestlé Add | Baader Bank | |
13.02.25 | BAT Sector Perform | RBC Capital Markets | |
13.02.25 | Siemens Outperform | RBC Capital Markets | |
13.02.25 | BAT Buy | UBS AG | |
13.02.25 | BAT Neutral | JP Morgan Chase & Co. | |
13.02.25 | Unilever Underperform | Jefferies & Company Inc. | |
13.02.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
13.02.25 | Rio Tinto Neutral | UBS AG | |
13.02.25 | Sanofi Buy | UBS AG | |
13.02.25 | EssilorLuxottica Buy | Jefferies & Company Inc. | |
13.02.25 | Siemens Buy | Deutsche Bank AG | |
13.02.25 | Nestlé Underperform | Jefferies & Company Inc. | |
13.02.25 | Nestlé Outperform | RBC Capital Markets | |
13.02.25 | Siemens Buy | Jefferies & Company Inc. | |
13.02.25 | VINCI Buy | Jefferies & Company Inc. | |
13.02.25 | Santander Buy | Goldman Sachs Group Inc. | |
13.02.25 | EssilorLuxottica Buy | Goldman Sachs Group Inc. | |
13.02.25 | EssilorLuxottica Overweight | JP Morgan Chase & Co. | |
13.02.25 | Novartis Neutral | UBS AG | |
13.02.25 | AstraZeneca Buy | UBS AG | |
13.02.25 | EssilorLuxottica Outperform | RBC Capital Markets | |
12.02.25 | EssilorLuxottica Neutral | UBS AG | |
12.02.25 | VINCI Buy | UBS AG | |
12.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
12.02.25 | AstraZeneca Hold | Deutsche Bank AG |